CD22 and B-cell chronic lymphocytic leukemia: To further test the role of CD22, and to explore the relevance of the RBC suppressive mechanism to a human disease, we took advantage of findings that the lectin CD22 is expressed at only low levels by malignant B cells in patients with CLL [24].